debate: prostate cancer patients should/should not get chemo and adt as a standard of care
Published 7 years ago • 2.2K plays • Length 22:00Download video MP4
Download video MP3
Similar videos
-
8:36
the importance of diagnosing and treating oligometastatic prostate cancer and adt usage
-
19:50
new standards of care for advanced prostate cancer
-
20:46
debate: effectiveness of surgery versus radiation in treating prostate cancer
-
10:38
updates in treatment using adt and anti-androgens
-
6:46
metastasis-directed therapy: radiation oncology updates and perspective
-
9:44
debate: surgery vs. brachytherapy for intermediate and high-risk prostate cancer - surgery
-
27:50
new concepts in adt
-
40:09
adt as foundational therapy: consistent t suppression, goals, monitoring, and delaying time to crpc
-
2:03
metastatic prostate cancer: can urologists work alongside medical oncologists in advanced disease?
-
27:05
adt for prostate cancer: agonists vs antagonists
-
14:55
testosterone treatment and prostate cancer risk
-
21:18
rationale for focal therapy for prostate cancer
-
22:53
point counterpoint: early chemotherapy is better
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
13:26
radiation oncology perspective: image-guided metastasis-directed therapy
-
22:55
update on mechanisms of resistance in castration-resistant prostate cancer
-
5:08
cardiovascular & metabolic risk profiles of hormonal agents for managing advanced prostate cancer
-
18:55
debate: how should we manage oligometastatic disease?
-
28:19
targeting ar in castration resistant prostate cancer
-
20:21
imaging alternatives for psma negative #prostatecancer patients | #markscholzmd #alexscholz #pcri
-
5:56
stories of advanced prostate cancer survivors | ask a prostate expert, mark scholz, md
-
15:37
choosing systemic therapy for men with metastatic hormone sensitive prostate cancer